A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval

The rising outbreak of SARS-CoV-2 continues to unfold all over the world. The development of novel effective antiviral drugs to fight against SARS-CoV-2 is a time cost. As a result, some specific FDA-approved drugs have already been repurposed and authorized for COVID-19 treatment. The repurposed dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashour, Nada A, Abo Elmaaty, Ayman, Sarhan, Amany A, Elkaeed, Eslam B, Moussa, Ahmed M, Erfan, Ibrahim Ali, Al-Karmalawy, Ahmed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935998/
https://www.ncbi.nlm.nih.gov/pubmed/35321497
http://dx.doi.org/10.2147/DDDT.S354841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935998/
https://www.ncbi.nlm.nih.gov/pubmed/35321497
http://dx.doi.org/10.2147/DDDT.S354841

Ejemplares similares